Cupping Therapy South Morang

Cupping therapy at our South Morang clinic offers patients a clinically informed, non-invasive treatment option for musculoskeletal pain, muscular tightness and restricted movement. By applying controlled negative pressure to the skin and superficial myofascial tissues, cupping gently lifts and decompresses soft tissue layers, encouraging local blood flow, fluid movement and sensory input that may assist with pain modulation and reduced protective muscle tone.

Experimental imaging research has shown that low-pressure cupping can improve local circulation, vessel dilation, tissue oxygenation and lymphatic clearance, while systematic reviews published through BMJ Open and PubMed-indexed databases report short-term reductions in pain intensity for chronic musculoskeletal pain, neck pain and low back pain.

Evidence quality remains variable, and cupping is best used as part of a broader myotherapy treatment plan; however, for patients presenting with neck, shoulder, back or sports-related muscular tension, cupping may support symptom relief, improved tissue mobility and more comfortable functional movement

Cupping therapy in South Morang may assist patients experiencing a range of musculoskeletal pain presentations, particularly where muscular tightness, restricted movement and sensitised soft tissue are contributing to discomfort. At our South Morang clinic, cupping is commonly used as part of a broader myotherapy treatment plan for areas such as neck pain, low back pain, chronic back or shoulder tension, and generalised musculoskeletal pain.

Cuppping may help improve local circulation, reduce soft tissue restriction and provide sensory input that supports short-term pain modulation. Systematic reviews indexed through PubMed and published in journals including BMJ Open have reported that cupping therapy may reduce pain intensity in chronic musculoskeletal pain, neck pain and low back pain, with evidence also suggesting potential benefit in conditions such as knee osteoarthritis. While current research indicates cupping can be a helpful non-pharmacological option for short-term symptom relief, the quality of evidence varies, so it is best applied alongside clinical assessment, movement-based rehabilitation and hands-on myotherapy care.

The therapeutic effects of cupping therapy are grounded in well-characterised peripheral, spinal, and supraspinal neurophysiological mechanisms that extend far beyond its traditional explanatory models. At the tissue level, the application of a vacuum cup to the skin and underlying fascia generates a sustained negative pressure that mechanically decompresses and lifts myofascial structures, creating a tensile strain through the dermal, subdermal, and fascial layers.

The findings of a randomised controlled trial on pulsatile dry cupping in patients with chronic low back pain suggest that cupping exerts analgesic effects through the stimulation of cutaneous mechanoreceptors, leading to segmental inhibition of pain transmission.

This mechanoreceptor activation is specific and anatomically significant. Four major types of encapsulated mechanoreceptors are specialised to provide information to the central nervous system about touch, pressure, vibration, and cutaneous tension: Meissner's corpuscles, Pacinian corpuscles, Merkel's discs, and Ruffini's corpuscles — all innervated by large myelinated Aβ axons, ensuring rapid central transmission of tactile information. The sustained negative pressure of cupping is particularly effective at engaging Ruffini corpuscles and Merkel discs, which respond to static pressure and skin stretch, while the dynamic application and release of cups recruits the rapidly adapting Meissner and Pacinian receptors sensitive to movement and vibration. Critically, Ruffini and Pacinian corpuscles are also present within fascia itself — Ruffini corpuscles monitoring persistent postural input, while Pacinian receptors respond to transient mechanical changes — meaning cupping simultaneously activates mechanoreceptive populations across both skin and deep connective tissue.

At the spinal level, the most compelling analgesic mechanism for cupping therapy is the activation of A-delta, A-beta, and C-fibres, which inhibit afferent nociceptive input to the dorsal horn. This is consistent with the gate control theory of pain, first described by Melzack and Wall, wherein cupping stimulates large nerve fibres, leading to inhibition of pain signal transmission to the brain via the dorsal horn of the spinal cord, triggering up-regulation of receptor-fibre units and stimulation of peripheral nociceptors. In practical terms, the high-volume sensory barrage generated by mechanoreceptor activation preferentially floods the dorsal horn with large-fibre input, effectively closing the gate to ascending nociceptive traffic. According to the pain-gate model, negative pressure suppresses pain through mechanoreceptor stimulation of nerve impulses that close the gates; furthermore, conditioned pain modulation suggests that cupping stimulates the skin to trigger autonomous, hormonal, and immune reactions that activate the neuroendocrine-immune system and reduce pain.  

Beyond segmental gating, cupping engages supraspinal inhibitory systems through Diffuse Noxious Inhibitory Controls (DNIC) and their human equivalent, conditioned pain modulation (CPM). DNIC refers to pain inhibition mediated by the lower brainstem; in humans this is called conditioned pain modulation, and its effective utilisation entails using conditioning stimuli to attain a reduced pain response. Cupping therapy has been applied in the treatment of idiopathic pain syndromes through mechanisms that may include initiation of a DNIC response. DNIC is mediated via descending pain inhibitory pathways, with key CNS regions including the ipsilateral dorsolateral funiculus and the medullary subnucleus reticularis dorsalis, and involves neurotransmitter systems including noradrenaline and serotonin — both of which are rapidly activated by nociceptive and mechanosensory stimuli.

At the neurochemical level, additional explanations for cupping's analgesic effects include modulation of descending inhibitory pathways and increased beta-endorphin levels. Cupping-mediated analgesia may also contribute to the activation of mechanoreceptors in the periphery, resulting in the release of endogenous anandamide and opioids. Like needle manipulation during acupuncture, cupping may provide sufficient mechanical stimulation to activate TRPv1 receptors on peripheral nerve endings, propagating an intercellular calcium wave and expelling ATP via pannexin channels, which break down to adenosine. Adenosine, in turn, acts on A1 receptors at the spinal level to further suppress nociceptive transmission — a mechanism now well-established in the acupuncture and manual therapy literature.

 

The autonomic nervous system is also meaningfully engaged. It has been proposed that cupping influences the autonomic nervous system via dermatomal stimulation, impacting not only pain perception but also visceral function — with the reflex arc model providing a neurophysiological explanation for improvements in both localised and referred pain. Evidence from heart rate variability (HRV) research supports this: the autonomic nervous system response to cupping applied to the back is dependent on the magnitude of negative pressure applied, with medium-to-high negative pressure at −300 and −500 mmHg producing significant improvements in heart rate variability. IJCRTnih

At the sensorimotor integration level, cupping produces meaningful changes in how the central nervous system perceives and maps the treated region. By stimulating mechanoreceptors and proprioceptive nerve endings, cupping can encourage the brain to permit a more extensive range of motion and improved motor control, with sensory input modulating pain perception — when the brain receives this new afferent input, it may prioritise it over existing pain signals, effectively reducing pain perception. This is consistent with research showing that touch therapy increases the release of nerve growth factor, which aids in rewiring the brain for improved motor patterning and decreasing loss of proprioception in areas of chronic pain and cortical dissociation.

Peripherally, the haemodynamic and biochemical environment is simultaneously remodelled. The sustained negative pressure drives local reactive hyperaemia, increasing microcirculatory perfusion, restoring tissue oxygenation, and facilitating removal of accumulated metabolic waste products — including the nociceptive mediators that sustain peripheral sensitisation in chronic pain states. Clinical evidence demonstrates that cupping increases pressure-pain thresholds, consistent with a reduction in peripheral sensitisation of deeper tissues.

Collectively, these converging peripheral, spinal, and supraspinal mechanisms — mechanoreceptor-driven gate control, endogenous opioid and adenosine release, DNIC-mediated descending inhibition, autonomic modulation, and restoration of central sensorimotor mapping — explain how cupping, applied by a skilled clinician, achieves clinically meaningful reductions in pain sensitivity, improvements in tissue mobility, and interruption of the neurophysiological drivers of both acute and chronic musculoskeletal pain. Far from a passive or placebo-dependent modality, cupping engages a rich and well-characterised cascade of neurophysiological responses that parallel those seen with other evidence-based manual and neuromodulatory therapies. 

1. Furhad, S., Sina, R. E., & Bokhari, A. A. (2023, October 30). Cupping therapy. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538253/

2. Jia, Y., Dong, X., Chai, Y., Bai, Z., Sun, T., & Hou, X. (2025). Effects of cupping therapy on chronic musculoskeletal pain and collateral problems: A systematic review and meta-analysis. BMJ Open, 15(5), e087340. https://doi.org/10.1136/bmjopen-2024-087340

3. Li, Y., Mo, P. C., Jain, S., Elliott, J., Bleakney, A., Lyu, S., & Jan, Y. K. (2022). Effect of durations and pressures of cupping therapy on muscle stiffness of triceps. Frontiers in Bioengineering and Biotechnology, 10, 996589. https://doi.org/10.3389/fbioe.2022.996589

4. Lauche, R., Cramer, H., Hohmann, C., Choi, K. E., Rampp, T., Saha, F. J., Musial, F., Langhorst, J., & Dobos, G. (2012). The effect of traditional cupping on pain and mechanical thresholds in patients with chronic nonspecific neck pain: A randomised controlled pilot study. Evidence-Based Complementary and Alternative Medicine, 2012, 429718. https://doi.org/10.1155/2012/429718

5. Schumann, S., Lauche, R., Irmisch, G., Hohmann, C., Rolke, R., Saha, J., Cramer, H., Choi, K., Langhorst, J., Rampp, T., Dobos, G., & Musial, F. (2012). The effects of five sessions of cupping massage on chronic non-specific neck pain: A randomized controlled pilot study. BMC Complementary and Alternative Medicine, 12(Suppl 1), P220. https://doi.org/10.1186/1472-6882-12-S1-P220

6. Wang, X., Zhang, X., Elliott, J., Liao, F., Tao, J., & Jan, Y. K. (2020). Effect of pressures and durations of cupping therapy on skin blood flow responses. Frontiers in Bioengineering and Biotechnology, 8, 608509. https://doi.org/10.3389/fbioe.2020.608509

7. Yarnitsky, D., Granot, M., & Granovsky, Y. (2023). Diffuse noxious inhibitory controls and conditioned pain modulation: A shared neurobiology within the descending pain inhibitory system? Pain, 164(Suppl 1), S34–S39. https://doi.org/10.1097/j.pain.0000000000002878

8. Cobo, R., García-Piqueras, J., Cobo, J., & Vega, J. A. (2021). The human cutaneous sensory corpuscles: An update. Journal of Clinical Medicine, 10(2), 227. https://doi.org/10.3390/jcm10020227

9. Purves, D., Augustine, G. J., Fitzpatrick, D., Hall, W. C., LaMantia, A. S., & White, L. E. (Eds.). (2012). Mechanoreceptors specialized to receive tactile information. In Neuroscience (5th ed.). Sinauer Associates. https://www.ncbi.nlm.nih.gov/books/NBK10895/

10. Schwartz, J., & Miao, J. H. (2023, July 24). Neuroanatomy, touch receptor. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK547731/